Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1478-811X
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Inhibition of CRM1 activity sensitizes endometrial and ovarian cell lines to TRAIL-induced cell death ; volume:16 ; number:1 ; day:4 ; month:7 ; year:2018 ; pages:1-16 ; date:12.2018
Cell communication and signaling ; 16, Heft 1 (4.7.2018), 1-16, 12.2018
- Creator
-
Fabi, François
- Contributor
-
Adam, Pascal
Vincent, Keven
Demontigny, Françis
Parent, Sophie
Joncas, France-Hélène
Asselin, Eric
SpringerLink (Online service)
- DOI
-
10.1186/s12964-018-0252-z
- URN
-
urn:nbn:de:101:1-2018091212553801773241
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:25 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fabi, François
- Adam, Pascal
- Vincent, Keven
- Demontigny, Françis
- Parent, Sophie
- Joncas, France-Hélène
- Asselin, Eric
- SpringerLink (Online service)
Other Objects (12)
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin
Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL-mediated apoptosis
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin
Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL-mediated apoptosis
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Investigation of TRAIL resistance in ovarian cancer cell lines and translational application in primary ovarian cancer cells
Methylsulfonylmethane sensitizes endometrial cancer cells to doxorubicin
Trastuzumab Sensitizes Ovarian Cancer Cells to EGFR-targeted Therapeutics
Stigmasterol sensitizes endometrial cancer cells to chemotherapy by repressing Nrf2 signal pathway
ARID1A mutation sensitizes most ovarian clear cell carcinomas to BET inhibitors
Bortezomib sensitizes neuroblastoma for TRAIL-induced apoptosis
miR-494 Sensitizes Gastric Cancer Cells to TRAIL Treatment Through Downregulation of Survivin
Proteomics informed by transcriptomics reveals Hendra virus sensitizes bat cells to TRAIL-mediated apoptosis
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation
Knockdown of the stem cell marker Musashi-1 inhibits endometrial cancer growth and sensitizes cells to radiation